For people living with multiple sclerosis (MS), the COVID-19 pandemic introduced a layer of complexity to an already challenging condition. MS is an autoimmune disease where the immune system mistakenly attacks the protective covering of nerves, leading to communication problems between the brain and the body. With a weakened or dysregulated immune system,
multiple sclerosis and covid vaccine individuals with MS often face tough questions about vaccines—especially the COVID-19 vaccine. Should they get it? Could it worsen their MS? Will it provide enough protection?
These concerns are valid. The interplay between MS, disease-modifying therapies (DMTs), and vaccines requires careful consideration. But for most people with MS, the benefits of the COVID-19 vaccine far outweigh the risks. Understanding why involves looking at the science, the data, and the lived experiences of those with MS who have received the vaccine.
How MS and the COVID-19 Vaccine Interact
Multiple sclerosis itself does not inherently increase the risk of contracting COVID-19. However, some factors associated with MS can influence vulnerability:
- Immunomodulatory therapies: Many people with MS take medications that suppress or alter immune function. These therapies can reduce the body’s ability to fight off infections, including COVID-19.
- Mobility issues: Limited mobility may increase exposure risk in group settings or care facilities.
- Comorbidities: Conditions like diabetes, heart disease, or lung disease—more common in people with MS—can complicate COVID-19 outcomes.
The COVID-19 vaccine, therefore, becomes a critical tool for prevention. But how does it affect MS? The answer lies in understanding the immune response.
The Immune Response in MS
MS is driven by an overactive immune system attacking the central nervous system. Vaccines, including COVID-19 vaccines, stimulate the immune system to recognize and fight the virus. This has led to concerns that the vaccine could trigger or worsen MS relapses.
However, clinical data and real-world experience suggest otherwise. Studies show that COVID-19 vaccines do not increase the risk of MS relapses or progression. In fact, the immune response generated by the vaccine is targeted and temporary, unlike the chronic, misdirected inflammation seen in MS flare-ups.
What the Research Says
Multiple studies have examined the relationship between COVID-19 vaccination and MS activity. Key findings include:
- No increased relapse risk: A 2022 study published in Neurology: Neuroimmunology & Neuroinflammation found that COVID-19 vaccination did not increase the risk of MS relapses in the weeks following vaccination. Relapse rates were comparable to pre-pandemic levels.
- Safe for most MS therapies: People on disease-modifying therapies (DMTs)—especially those that suppress the immune system—were included in vaccine trials. No evidence suggests these medications interfere with vaccine safety.
- Effective protection: While some DMTs may reduce vaccine efficacy, the vaccines still provide partial protection and reduce the risk of severe COVID-19 outcomes.
One concern is with anti-CD20 therapies (e.g., ocrelizumab, rituximab), which deplete B cells and can weaken vaccine response. People on these drugs may produce fewer antibodies, but T-cell responses—another part of the immune defense—remain intact. Booster doses and timing vaccinations around DMT infusions can help optimize protection.
Addressing Common Concerns
Despite the reassuring data, misconceptions persist. Let’s address some of the most common concerns:
1. “Will the vaccine trigger an MS relapse?”
There is no evidence that COVID-19 vaccines cause MS relapses. Relapses can occur spontaneously or due to infections, stress, or other factors unrelated to vaccination. The vaccine’s immune response is short-lived and specific, unlike the ongoing inflammation in MS.
2. “Is the vaccine safe for people with progressive MS?”
Yes. People with primary-progressive MS (PPMS) or secondary-progressive MS (SPMS) were included in vaccine trials and real-world studies. Their experiences mirrored those of people with relapsing-remitting MS (RRMS): no increased risk of disease activity.
3. “What if I’m on a strong immunosuppressant?”
Even with medications that suppress the immune system, the benefits of vaccination still apply. While antibody responses may be reduced, the vaccine can still prevent severe disease and hospitalization. It’s important to discuss timing with your neurologist—vaccinating before or after DMT infusions can optimize immune response.
4. “Should I delay the vaccine if I’m planning to start a new DMT?”
Timing matters. Some neurologists recommend getting the vaccine at least two weeks before starting a new DMT to allow for a stronger immune response. Others may suggest waiting until after the initial immune activation period of the vaccine. Always consult your healthcare provider to personalize your plan.
Practical Steps for People with MS
If you have MS and are considering the COVID-19 vaccine, here are practical steps to ensure safety and effectiveness:
1. Talk to Your Neurologist
Before getting vaccinated, have a conversation with your neurologist. Discuss:
- Your current DMT and its impact on immune function.
- The best timing for vaccination relative to your treatment schedule.
- Any concerns about previous vaccines or allergies.
2. Get the Updated Booster
COVID-19 variants continue to emerge, and updated booster shots (targeting newer variants like Omicron) provide better protection than original vaccines. People with MS are encouraged to stay up to date with annual boosters, especially if they are on immunosuppressants.
3. Monitor Symptoms After Vaccination
While rare, some people may experience mild side effects after the vaccine, such as:
- Fatigue
- Headache
- Muscle aches
- Low-grade fever
These symptoms are temporary and usually resolve within a few days. Importantly, they are not signs of MS relapse.
4. Continue Other Preventive Measures
Vaccination doesn’t eliminate risk entirely. Continue practicing good hygiene, wearing masks in high-risk settings, and avoiding close contact with people who are sick—especially during flu season or COVID-19 surges.
5. Stay Informed
Guidelines may evolve as new data emerges. Rely on trusted sources like the National MS Society, the CDC, or your healthcare provider for updates.
The Bigger Picture: Protecting the Community
Getting vaccinated isn’t just about individual health—it’s about community protection. People with MS, especially those on immunosuppressants, may not mount a strong immune response. By getting vaccinated, you help reduce the spread of COVID-19 and protect those who are most vulnerable.
This act of prevention aligns with the compassionate and proactive spirit of managing a chronic condition. It’s about taking control, making informed choices, and contributing to a safer world for everyone.
Final Thoughts: A Shot at Peace of Mind
Living with MS comes with enough uncertainty. The COVID-19 vaccine doesn’t have to be one of them. The data is clear: the benefits of vaccination far outweigh the risks for people with MS. It offers a layer of protection, reduces the chance of severe illness, and provides peace of mind in uncertain times.
If you’re still hesitant, talk to your doctor, review the research, and connect with others in the MS community who have been vaccinated. You’ll likely find that most have experienced no issues—and gained a sense of security.